Prothena Corp. plc Stock
Prothena Corp. plc Stock
We can see a decrease in the price for Prothena Corp. plc. Compared to yesterday it has lost -€0.104 (-1.420%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Prothena Corp. plc.
With a target price of 15 € there is potential for a 118.72% increase which would mean more than doubling the current price of 6.86 € for Prothena Corp. plc.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -1.420% | -10.680% | -24.704% | 48.442% | -16.366% | -89.449% | -81.262% |
| Heron Therapeutics Inc. | 5.540% | -7.752% | -65.640% | -80.843% | -68.169% | -69.431% | -97.164% |
| Evolus Inc | -0.690% | 9.624% | 5.568% | -33.529% | 3.670% | -26.144% | -36.872% |
| Rhythm Pharmaceuticals | -0.680% | 2.740% | -6.250% | 30.435% | -19.786% | 368.750% | 390.196% |
Comments
Prothena (PRTA) had its "outperform" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat